[HTML] cell.com

[HTML][HTML] miR-146b-5p enhances the sensitivity of NSCLC to EGFR tyrosine kinase inhibitors by regulating the IRAK1/NF-κB pathway

YN Liu, MF Tsai, SG Wu, TH Chang, TH Tsai… - … Therapy-Nucleic Acids, 2020 - cell.com
Although patients with non-small cell lung cancer harboring activating mutations in the
epidermal growth factor receptor (EGFR) show good clinical response to EGFR tyrosine …
被引用次数：32 相关文章
[HTML] sciencedirect.com

[HTML][HTML] miR-146b-5p Enhances the Sensitivity of NSCLC to EGFR Tyrosine Kinase Inhibitors by Regulating the IRAK1/NF-κB Pathway

YN Liu, MF Tsai, SG Wu, TH Chang, TH Tsai… - … Therapy-Nucleic Acids, 2020 - Elsevier
Although patients with non-small cell lung cancer harboring activating mutations in the
epidermal growth factor receptor (EGFR) show good clinical response to EGFR tyrosine …
[HTML] nih.gov

[HTML][HTML] miR-146b-5p Enhances the Sensitivity of NSCLC to EGFR Tyrosine Kinase Inhibitors by Regulating the IRAK1/NF-κB Pathway

YN Liu, MF Tsai, SG Wu, TH Chang… - Molecular Therapy …, 2020 - ncbi.nlm.nih.gov
Although patients with non-small cell lung cancer harboring activating mutations in the
epidermal growth factor receptor (EGFR) show good clinical response to EGFR tyrosine …

miR-146b-5p Enhances the Sensitivity of NSCLC to EGFR Tyrosine Kinase Inhibitors by Regulating the IRAK1/NF-κB Pathway

YN Liu, MF Tsai, SG Wu, TH Chang… - Molecular therapy …, 2020 - pubmed.ncbi.nlm.nih.gov
Although patients with non-small cell lung cancer harboring activating mutations in the
epidermal growth factor receptor (EGFR) show good clinical response to EGFR tyrosine …

miR-146b-5p Enhances the Sensitivity of NSCLC to EGFR Tyrosine Kinase Inhibitors by Regulating the IRAK1/NF-κB Pathway.

YN Liu, MF Tsai, SG Wu, TH Chang… - Molecular therapy …, 2020 - europepmc.org
Although patients with non-small cell lung cancer harboring activating mutations in the
epidermal growth factor receptor (EGFR) show good clinical response to EGFR tyrosine …